Join
Live feed
·
PRReleasevia Quantisnow
NovaBay Pharmaceuticals Inc. logo

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

ByQuantisnow·Wall Street's wire, on your screen.
NBY· NovaBay Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBY (NovaBay Pharmaceuticals Inc.) and more on Quantisnow.